|
|
|
|
|
by sam-2727
1644 days ago
|
|
I think this is a great idea theoretically, but in reality for most papers I don't want to see the data/underlying code. While it would be great to publish data/code with the paper (in the field I've worked on the most, astronomy, most data is already published with the paper anyways), I don't want/need to look through a notebook with the underlying code of the paper in order to just read the intro/conclusions (and maybe one key methods section). Interactive figures are a great idea, but again, oftentimes I don't really care to interact with the figure, or fiddle stuff around, I just want to know why the paper is important and how I should use its conclusions. The two-column format of most papers is very useful for skimming. So instead I would argue notebooks shouldn't replace papers, but supplement them (as they sometimes do already, in fact, but perhaps journals could make it an actual requirement to create a supplementary notebook). As the article mentions, scientific fields are gigantic nowadays, and skimming papers is critical when you're citing 100+ references in your paper. |
|
IMHO, the biggest problem with papers is politics and reviews. In many top journals like Nature there's no double-blind review (actually in Nature it's now optional but big groups never use it). And even if there was double-blind review, referees have no skin in the game. So the usual outcome is to get reviewed by a big name in your field, who is actually interested in controlling research trends and killing "competitors".
This is hindering progress and hurting new ideas. For example, proponents of Alzheimer's disease being caused by an infection or dysbiosis have had a hard time to do research, get grants and publish articles during the last 2 decades. Despite their theory is able to explain the etiology quite well, unlike competing alternatives.
Another problem is that to publish in good journals you need cool results. Cool results are rare, but Nature, Science, Cell et al. are full of articles every month. So, most groups are overselling and misreporting things. Research fraud, p-value hacking and data manipulation are really common.